Signs and Symptoms: Pain Skin and Connective Tissue Diseases Other disorders of skin and subcutaneous tissue, not elsewhere classified
Conditions
Interventions
Prospective randomised controlled cross-over trial with questionnaire and interviews. Topical opioids versus placebo.
Sponsors
Department of Health (UK)
Eligibility
Inclusion criteria
Inclusion criteria: 20 Patients with chronic painful leg ulcers, from all inpatients at the Walsgrave Hospital (powered to give 75-80% preference rate of either active or placebo gel).
Exclusion criteria
Exclusion criteria: Does not match inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PRN (pro re nata - as needed) and regular analgesia requirement over preceding 24 h. Daily pain score and questionnaire regarding side-effects. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed